Tobias Wertheimer

9PUBLICATIONS
82CO-AUTHORS
Genomics and transcriptomicsHaematological tumoursMolecular targetsRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 30, 2026
CytoVI: deep generative modeling of antibody-based single cell data.

|Sep 05, 2026
Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

|Jan 27, 2025
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.

Marcel Fabian Pohly, Kerstin Putzker, Sebastian Scheinost

|Apr 18, 2023
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.

Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld

|Jan 17, 2023
Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success.

Antonia-Maria Pausch, Tamam Ghali, Tobias Wertheimer

|Jul 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus

Pageof 2

Frequent Collaborators

4 joint publications

Robert Zeiser

3 joint publications

Burkhard Becher

2 joint publications

Justus Duyster

2 joint publications

Melanie Börries